Article
BRAFV600E Mutation-Responsive miRNA-222-3p Promotes Metastasis of Papillary Thyroid Cancer Cells via Snail-Induced EMT.
Frontiers in endocrinology - 1 Jan 2022
Gao Yuan, Xiang Dapeng, Li Weijie, Zheng Xi, Wang Lin, Li Zhiyu, Chen Ting
Abstract excerpt
BRAF mutation accounts for 50% of the PTC (papillary thyroid carcinoma) and is closely associated with high-risk clinicopathological characteristics. Increasing evidence implied that dysregulation of miRNA participated in carcinogenesis and progression of cancer. Clinical data showed the significant up-regulation of miR-222-3p in PTC; however, the role of miR-222-3p and possible relationship with BRAF mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
